Future of Biotech at the SyntecBio AI & Digital Biotech Conference
Ready to see where artificial intelligence and digital innovation will take biotech in 2025? Join us October 14–16 in Boston for the SyntecBio AI & Digital Biotech Conference—three days of cutting-edge insights, hands-on workshops, and unparalleled networking with the brightest minds in AI-driven drug discovery and digital therapeutics.
Why Attend?
- Front-Row Access to Innovation
Hear keynote addresses from leaders who are shaping tomorrow’s medicines with machine learning, from protein-structure prediction to patient-centered digital therapeutics. - Deep-Dive Technical Sessions
Choose from 12 concurrent tracks covering:- AI in Lead Optimization: New algorithms that deliver higher hit rates, faster.
- Digital Biomarkers & Wearables: Turning continuous patient data into actionable insights.
- Regulatory Pathways for DTx: Navigating FDA and CE marking for therapeutic software.
- Practical Workshops
Roll up your sleeves in small-group tutorials on:- Building custom model pipelines with SyntecBio’s SDK
- Designing hybrid clinical trials that integrate digital endpoints
- Unrivaled Networking
Connect with 500+ attendees from biotech startups, Big Pharma, health-tech investors, and regulatory bodies. Our curated “Speed-Match” sessions pair you with potential partners in 10-minute meet-and-greets.
Featured Highlights
1. Keynote: AI-Driven Drug Discovery at Scale
Dr. Priya Natarajan, Head of Computational Chemistry at Novaventis, shares how her team used deep-learning models to slash lead-candidate timelines by 60%.
2. Panel: From Data to Decision—Building Trust in AI
A cross-industry discussion moderated by SyntecBio’s CTO Daniel Kim, featuring experts from the FDA, WHO, and top academic labs.
3. Innovation Showcase
Explore live demos from early-stage startups and SyntecBio partners presenting breakthroughs in:
- AI-powered gene therapy design
- Remote patient monitoring tools
- Blockchain-enabled clinical-trial data integrity
Who Should Attend?
- Biotech & Pharma Executives seeking strategic insights to integrate AI and digital into their pipelines.
- Data Scientists & Bioinformaticians looking for best practices in model development and validation.
- Clinicians & Digital-Therapeutics Developers interested in the latest evidence on patient engagement and outcomes.
- Investors & VCs scouting the next wave of high-impact digital-health innovations.
Registration & Early-Bird Savings
Secure your spot by July 31 to save 20% on all pass types:
- Full Conference Pass (All sessions + workshops + meals)
- One-Day Pass (Pick your day—Keynotes + panels + exhibition)
- Student Pass (Proof of enrollment required)
Visit syntec.bio/conference to register, view the detailed agenda, and learn about sponsorship opportunities.
Join Us and Shape the Next Wave of Biotech
The fusion of AI and digital therapeutics is rewriting the rules of drug development and patient care. Don’t miss your chance to be at the epicenter of this transformation. We’ll see you in Boston this October!
About Syntec Bio inc
SyntecBio is a Boston, Massachusetts–based innovator leveraging AI to accelerate biotech R&D. Founded in 2018, its platform powers over 50 drug-discovery partnerships and has advanced more than a dozen programs into preclinical and clinical stages.
